Product Details
Semaglutide Injection
Semaglutide1.34 mg/mL
Solution for Injection
3-mL (4 mg) Prefilled Pen
DIN/PIN/NPN
02567814
Manufacturer
Dr. Reddy's Laboratories Inc.
Formulary Listing Date
2026-06-30
Unit Price
78.1410
Amount MOH Pays
78.1410
Coverage Status
Limited Use Product Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A10BJ06
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02471469 | Ozempic | 227.9400 | 78.1410 |
| 02568012 | Apo-Semaglutide Injection | 78.1410 | 78.1410 |
| 02567814 | Semaglutide Injection | 78.1410 | 78.1410 |
LU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 665 | Indefinite | For the treatment of adult patients with type 2 diabetes when adequate glycemic control is not achieved on the maximum tolerated dose of metformin or where metformin is contraindicated or inappropriate. Semaglutide is not funded in combination with another glucagon-like peptide-1 receptor agonist (GLP-1 RA) or dipeptidyl peptidase-4 (DPP-4) inhibitor. Injectable semaglutide is not funded in combination with oral semaglutide. Coverage is only provided for one dosage format. Reimbursed dose: As per the product monograph |
Requirements